HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Heydemann Selected Research

Peter Heydemann Research Topics

Disease

2Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2022 - 01/2017
2Congenital Toxoplasmosis
12/2011 - 05/2006
1Retinal Diseases
01/2022
1Neurodevelopmental Disorders
01/2020
1Rett Syndrome (Rett's Disorder)
01/2020
1Optic Atrophy
12/2017
1Mitochondrial Diseases (Mitochondrial Disease)
12/2017
1Heart Failure
10/2015
1Neurologic Manifestations (Neurological Manifestations)
03/2012
1Toxoplasmosis
12/2011

Drug/Important Bio-Agent (IBA)

2Pyrimethamine (Daraprim)FDA Link
03/2012 - 05/2006
2Sulfadiazine (Sulphadiazine)FDA Link
03/2012 - 05/2006
1eteplirsenIBA
01/2022
1Methyl-CpG-Binding Protein 2IBA
01/2020
1Oxidoreductases (Dehydrogenase)IBA
12/2017
1Ferredoxin-NADP Reductase (Adrenodoxin Reductase)IBA
12/2017
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
12/2017
1FlavoproteinsIBA
12/2017
1NADP (NADPH)IBA
12/2017
1Adenosine Triphosphate (ATP)IBA
12/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2017
1Ferredoxins (Ferredoxin)IBA
12/2017
1atalurenIBA
01/2017
1Nonsense Codon (Nonsense Mutation)IBA
01/2017
1VaccinesIBA
12/2011
1AntibodiesIBA
12/2011

Therapy/Procedure

2Therapeutics
10/2015 - 05/2006
1Ventriculoperitoneal Shunt
01/2022